The invention relates to a molding compound including a polyester resin composition, ABS components, waxes, matting agents and optionally vegetable oil, which is used to produce films with a low luster, improved thermal resistance of the film and/or of the surface structure and an increased shrinking onset temperature, in addition to a modified shrinkage progression in comparison to films without ...

A train protection and control system is disclosed which is suitable for use with an existing signalling system without requiring any functional change to the signalling system, the signalling system comprising a plurality of railway trackside devices (1), an interlocking (2) connected to the trackside devices (1) for controlling the trackside devices (1) and a control centre (3) connected to the ...

Sistema de localización espacial inalámbrico para la numeración, control y gestión remota de inventario de objetos, con, al menos, un elemento localizador o esclavo (1) situado sobre el objeto; un elemento controlador o maestro (13) que se comunica con el esclavo (1) a través de un primer enlace (15); un módulo móvil o mando (14) que se comunica con el esclavo (1) a través de un segundo enlace (15...

Agente de dispersión de suspensión acuosa de partículas minerales procedentes de una etapa de reconcentración mecánica y/o térmica consecutiva a una etapa de trituración por vía húmeda sin uso de dispersante y con baja concentración de materia seca, caracterizado por que dicho agente es un homopolímero, de ácido acrílico o un copolímero hidrosoluble de ácido acrílico con uno o más monómeros acríli...

The invention relates to peptides which contain N-methylated amino acid units and have improved water solubility. The invention also relates methods for treating a hormone-dependent tumor or a non-malignant indication that is treatable by LH-RH suppression, the method comprising administering to a patient in need of the treatment a therapeutically effective amount of a compound of the invention. H...

A closed loop therapy system for controlling a concentration of a substance, such as blood glucose concentration, in the body of a user. The system and method employ a sensor system that measures a glucose level in the body, a controller that uses the measured glucose levels to generate an output that can be used to automatically or manually control an intradermal insulin infusion system to set a ...

An actuator is disclosed which operates on the principle of the variable magnetic properties of materials with respect to temperature. As temperature is raised past Curie temperature, magnetic permeability of certain materials drops significantly to a value close to free space permeability. However, depending on the material selection, magnetic permeability may be significantly higher below Curie ...

The present invention relates to a drug combination comprising free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate and/or deoxyuridine monophosphate, and to the use of such a drug combination for treating e.g. diabetes.

The invention relates to the use of heterocycles containing trivalent phosphorus as a ring member as catalysts for isocyanate modification and to a process for prepari ng polyisocyanates of the trimer type.

La presente invencion se refiere a mezclas para la proteccion de plantas y a un metodo para mejorar la salud de plantas aplicando dichas mezclas sobre las plantas o el locus de las mismas.; Pesticidal mixtures comprising a) azolopyrimidinylamines of the formula I, in which the substituents are as defined in the specification, and b) at least one insecticidal compound II as defined in the specifica...

The present invention provides compounds of Formula I, (I) and salts, hydrates, solvates, complexes, and prodrugs thereof. The present invention further provides methods for synthesizing compounds of Formula I. The invention additionally provides pharmaceutical compositions comprising the compounds of Formula I and methods of using the pharmaceutical compositions of Formula I to treat and prevent ...

FIELD: chemistry. ^ SUBSTANCE: invention relates to novel compounds of formula (I) which can be used in diagnosis of tumorous diseases. In formula (I) , A is OH, C1-C5 alkoxy, N(C1-C5 alkyl)2, NH2; G is OH, O-C1-C5 alkyl; R1 and R2 independently denote H, 18F, 18F-C1-C5 alkoxy, 18F-C1-C5 alkyl, provided that if one of the substitutes R1 and R2 contain an 18F isotope, the other does not. The invent...

La presente invencion se relaciona con un cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato, composiciones farmaceuticas que comprenden este cristal y metodos para elaborar y utilizar este cristal.; The present invention relates to a novel crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate, pharmaceutical compositions comprising this crystal and, and methods of maki...

Esta invencion provee inhibidores de metaloproteasaa de matriz derivados de hterociclicos novedosos de la formula: y composiciones farmaceuticas que comprenden los mismos, utiles para tratar trastornos aliviados al antagonizar metaloproteasas de matriz; esta invencion tambien provee metodos terapeuticos y profilacticos que usan las presentes composiciones farmaceuticas.; This invention provides no...

A compound having the formula: which is of use in the preparation of HCV-nucleoside inhibitors.

Esta invencion se relaciona con moleculas de transporte novedosas que comprenden un polipeptido que comprende residuos de aminoacidos dispuestos en una secuencia que es la secuencia inversa de la porcion basica de la proteina HIV-TAT. Los polipeptidos de transporte novedosos son utiles para el suministro intracelular o de transmembrana de las moleculas de carga, ejemplos no limitantes de los cuale...

Esta invencion se relaciona con composiciones novedosas de toxina botulinum que se estabilizan utilizando fragmentos HIV-TAT o derivados de fragmentos HIV-TAT. La composicion se puede administrar para varios propositos terapeuticos, esteticos y/o cosmeticos. La invencion tambien proporciona un metodo para estabilizar la toxina botulinum utilizando los fragmentos HIV-TAT o derivados de los fragment...

A composition including an ethylene blocking agent complex formed from the product of an ethylene blocking agent and a host, and at least one water-soluble polymer, wherein the ethylene blocking agent complex and the at least one water-soluble polymer are intermingled is disclosed.

Mezclas fungicidas, que comprenden como componentes activos por lo menos una 1-metilpirazol-4-ilcarboxanilida de la formula I donde X= hidrogeno o fluor, R1= C1-alquino o C1-C4-haloalquino, R2= hidrogeno o halogeno, R3= hidrogeno, ciano, nitro, halogeno, C1-C4- alquino, C1-C4- haloalquilo, C1-C4- alcoxi.; Fungicidal mixtures, comprising as active components: 1) at least one 1-methylpyrazol-4-ylcar...

Procedimeinto de sintesis industrial del compuesto de formula (I).; Method for industrial synthesis of agomelatine comprises reaction of 7-methoxy-1-naphthol (II) with alkene compound (III) to obtain 7-methoxy-1-vinyl-naphthalene compound (IV); subjecting (IV) to catalytic hydrogenation to obtain methoxy-naphthalene compound (V); subjecting (V) to base or acid hydrolysis or with a binary reduction...